Composition :
Montelukast Sodium - 10 mg
Levocetirizine Dihydrochloride 5 mg
LUKAST LC Tablets is a combination of Montelukast Sodium & Levocetirizine Dihydrochloride. Montelukast sodium is an orally active compound that binds with high affinity and selectivity to the CysLT1 receptor. Montelukast inhibits physiologic actions of LTD 4 at the CysLT1 receptor without any agonist activity. It therefore acts as a leukotriene receptor antagonist Levocetirizine, the R-enantiomer of cetirizine, is a potent and selective antagonist of peripheral H1-receptors. It has been demonstrated by recent studies that the treatment of AR with concomitant administration of an antileukotriene (montelukast) and an antihistamine (levocetirizine), shows significantly better symptom relief compared with the modest improvement of rhinitis symptomatology with each of the treatments alone.
  • Seasonal & Perenial allergic rhinitis
  • Chronic treatment of asthma associated with allergy
  • Prophylactic treatment of asthma
  • Exercise induced asthma
  • Chronic idiopathic urticaria
Lukast LC USP/Advantages
  • Reduces broncho-constriction caused by the leukotriene
  • Once daily dosage improves patient compliance
  • Synergistic effect better than individual agent
  • Adults (>15years): 1 LUCAST LC Tablet once daily
  • Children (2-5years): 1 LUCAST LC Tablet once daily
DISCLAIMER : This product is available only in India against valid prescription from a Registered Medical Practitioner. This is not an offer for sale.